Literature DB >> 6702398

Recurrence risk after stapled anastomosis for rectal carcinoma.

A L Lasson, G R Ekelund, C G Lindström.   

Abstract

Forty patients operated upon for cure of carcinoma of the rectum with anterior resection using the EEA stapling device have been analyzed in an uncontrolled series. The recurrence rate during a mean follow-up of 39 months was 35%. The recurrence rate in all 62 patients with carcinomas operated upon with other techniques during the same period was 34%. The recurrence risk seemed to vary with stage and grade of the tumor growth, but the series is too small for valid conclusions. Preoperative selection of patients at high risk for local recurrence is difficult when only preoperative biopsies and peroperative findings are used as information.

Entities:  

Mesh:

Year:  1984        PMID: 6702398

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  5 in total

Review 1.  Analysis of local recurrence rates after surgery alone for rectal cancer.

Authors:  J L McCall; M R Cox; D A Wattchow
Journal:  Int J Colorectal Dis       Date:  1995       Impact factor: 2.571

2.  [Results of surgical therapy of rectal cancer at a regional hospital].

Authors:  M Kux; N Fuchsjäger; A Hirbawi; K Ghawidel
Journal:  Langenbecks Arch Chir       Date:  1988

3.  Pelvic recurrence after surgical treatment of rectal and sigmoid cancer. A prospective clinical trial on 274 patients.

Authors:  S Tagliacozzo; M Accordino
Journal:  Int J Colorectal Dis       Date:  1992-09       Impact factor: 2.571

4.  Low anterior resection versus abdominoperineal excision: a comparison of local recurrence after curative surgery for "very low" rectal cancer.

Authors:  D Tuscano; M Catarci; A Saputelli; F Gaj; F Gossetti; S Guadagni; P Negro; M Carboni
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

5.  The 'Holy Plane' of rectal surgery.

Authors:  R J Heald
Journal:  J R Soc Med       Date:  1988-09       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.